COLEMAN MARK sold 34.7% of their position (25K shares) of AXSOME THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.03M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2026ACC: 0001193125-26-083587
-25K
Net shares
Net seller
$4.03M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−25K
Price / share
$161.11
Trade value
$4.03M
% of position
34.7%
2/26/2026
72.14K→47.14K
Total
Net shares
−25K
Net value
-$4.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | S · Sale | −25K | $161.11 | $4.03M | 34.7% | 72.14K | 47.14K |
| Total | −25K | -$4.03M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned403.86K
Total
403.86K indirect403.86K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 403.86K | Indirect |
| Total | 403.86K | 403.86K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported